Search

Search Bar
01/05/2024 Impact of dose escalation on positive nodes in prostate cancer patients with pelvic nodal disease
Errasti, AM, Soto-Cambres, AM, Mitre, SJR, Ni o, LM, Calvet, G, Perez-Montero, H, Pardo, GS. Impact of dose escalation on positive nodes in prostate cancer patients with pelvic nodal disease. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).
01/05/2024 IS REIRRADIATION IN GYNAECOLOGICAL CANCER A REALITY? : A NATIONAL (SPANISH) SURVEY
Najjari-Jamal, D, Cordoba-Largo, S, Rovirosa, A, Sanchez-Belda, M, Majercakova, K, Garcia-Cabezas, S, Gimeno-Morales, M, Guevara-Barrera, D, Mu oz, T, De La Fuente, C, Mico, S, Matute, R. IS REIRRADIATION IN GYNAECOLOGICAL CANCER A REALITY? : A NATIONAL (SPANISH) SURVEY. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).
01/05/2024 EBH abdominal SBRT: inter- and intrafraction motion using two commercial monitoring systems
Ans n, C, Carrasco, P, Bermejo, S, Jimenez, J, Ventosa, N, Balart, J, Jornet, N, Gallego, P, P rez-Alija, J, Tejedor, N, Vivancos, H, Ruiz, A, Barcel , M, Leo, F, Dom nguez, A, Riu, V, Sancho, G. EBH abdominal SBRT: inter- and intrafraction motion using two commercial monitoring systems. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).
01/05/2024 Impact of coaching reinforcement on SGRT-guided abdominal SBRT with expiration breath-hold (EBH)
Bermejo, S, Ans n, C, Carrasco, P, Jim nez, J, Ventosa, N, de Segura, GG, Balart, J, Otero, E, Vizuete, A, Domenech, J, Suri ach, F, Soto, A, Farr , N, Jornet, N, Sancho, G. Impact of coaching reinforcement on SGRT-guided abdominal SBRT with expiration breath-hold (EBH). RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).
01/05/2024 Prognostic ability of TGF-ß and IL-6 in patients with HNSCC treated with RT
Montezuma, L, Leon-Vintr , X, Majerc kov , K, Juli , J, Farr , N, Rojas, J, Rabi, S, Crespo, S, Calvet, G, Camacho, M, Sancho, G. Prognostic ability of TGF-ß and IL-6 in patients with HNSCC treated with RT. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).
01/05/2024 Clinical and dosimetric predictors of cardiotoxicity for locally advanced lung cancer
Pla, EO, Cambres, AMS, Franco, PG, Sala, NJ, Rabi, S, P rez, SMC, Molinas, GC, Beltr n, JS, Recio, SM, Mart nez, SB, Pardo, GS, Bernad , NF. Clinical and dosimetric predictors of cardiotoxicity for locally advanced lung cancer. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).
01/05/2024 Treatment of rectal cancer in elderly patients >80 years might not be limited by their age
Pla, EO, Garc a, AJ, L pez, LR, Sanahuja, JCJ, Rabi, S, Molinas, GC, P rez, SMC, L pez-Bravo, DP, Manrique, ACV, Cullell, BM, Rodr guez, JB, S nchez, MCM, Pardo, GS, Serra, JB. Treatment of rectal cancer in elderly patients >80 years might not be limited by their age. RADIOTHERAPY AND ONCOLOGY. 2024; 194DOI:. PMID:. IF:5.300(Q1/2D).
11/02/2024 Criteria and indicators to evaluate quality of care in genitourinary tumour boards
Puente, J, Arrea, FA, Rueda, OB, Gauna, DC, Durán, I, Avila, JJF, Gómez-Iturriaga, A, Blázquez, MJP, Fentes, DP, Pardo, GS, Casas, JAV, Gratal, P, Pardo, MT, Porta, VG. Criteria and indicators to evaluate quality of care in genitourinary tumour boards. Clinical & Translational Oncology. 2024; 26(7)DOI:10.1007/s12094-024-03381-z. PMID:38341809. IF:2.500(Q3/6D).